Yoko Wada, Eriko Hasegawa, Ayako Wakamatsu, Yukiko Nozawa, Hiroe Sato, Takeshi Nakatsue, Takeshi Kuroda, Masaaki Nakano, Ichiei Narita. ACTIVATED PARTIAL THROMBOPLASTIN TIME REFLECTS THE DISEASE ACTIVITY IN BOTH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED SMALL VESSEL VASCULITIS AND TAKAYASU ARTERITIS. RHEUMATOLOGY. 2017. 56. 127-127
Yoko Wada, Eriko Hirose, Ayako Wakamatsu, Yukiko Nozawa, Hiroe Sato, Takeshi Nakatsue, Takeshi Kuroda, Masaaki Nakano, Ichiei Narita. LONG-TERM PROGNOSIS AND RENAL SURVIVAL IN JAPANESE PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS. RHEUMATOLOGY. 2017. 56. 105-106
Takeshi Nakatsue, Yukiko Nozawa, Hiroe Sato, Yoko Wada, Takeshi Kuroda, Masaaki Nakano, Ichiei Narita. INCREASING PREVALENCE OF OTITIS MEDIA WITH ANCA ASSOCIATED VASCULITIS REMEDIABLE WITH MILD IMMUNOSUPPRESSIVE THERAPY. RHEUMATOLOGY. 2017. 56. 147-147
Yoko Wada, Hiroe Sato, Takeshi Nakatsue, Shuichi Murakami, Takeshi Kuroda, Masaaki Nakano, Ichiei Narita. Serum Angiopoietin-2 Level Reflects the Disease Activity and Renal Function in Antineutrophilic Cytoplasmic Antibody-Associated Vasculitis. ARTHRITIS AND RHEUMATISM. 2012. 64. 10. S656-S656
T. Kuroda, D. Kobayashi, H. Sato, T. Nakatsue, Y. Wada, S. Murakami, M. Nakano, I. Narita. TREATMENT WITH BIOLOGIC AGENTS IMPROVES THE PROGNOSIS OF PATIENTS WITH RHEUMATOID ARTHRITIS AND AMYLOIDOSIS. ANNALS OF THE RHEUMATIC DISEASES. 2012. 71. 103-103